CAS 1332724-03-4

Citalopram Related Compound B (1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile oxalate)

CAS : 1332724-03-4

Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoi

Formule : C₂₂H₂₃FN₂O₆

Couleur et forme : Powder

Masse moléculaire : 430.15401

Ref: 45-1134255

Citalopram EP Impurity B Oxalate (Citalopram USP Related Compound B, Escitalopram EP Impurity B Oxalate, 3-Hydroxy Citalopram Oxalate)

CAS : 1332724-03-4

Formule : C₂₀H₂₁FN₂O₂·C₂H₂O₄

Couleur et forme : White To Off-White Solid

Masse moléculaire : 340.40 90.04

Ref: 4Z-C-0938

1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate

CAS : 1332724-03-4

Couleur et forme : Neat

Ref: 86-MM0242.21

Citalopram USP Related Compound B

CAS : 1332724-03-4

Formule : C₂₀H₂₁FN₂O₂C₂H₂O₄

Masse moléculaire : 340.40 : 90.0

Ref: ST-EA-CP-C23014

Escitalopram EP Impurity B

CAS : 1332724-03-4

Formule : C₂₀H₂₁FN₂O₂C₂H₂O₄

Masse moléculaire : 340.4 : 90.0

Ref: ST-EA-CP-E13002

3-Hydroxy citalopram oxalate

CAS : 1332724-03-4

3-Hydroxy citalopram oxalate (3HCO) is a drug product that is used as an analytical standard and impurity standard. It is synthesized in the laboratory by reacting 3,4-dihydroxyphenylacetic acid with citalopram, followed by esterification with oxalic acid. The purity of the final product is typically >98%.

Formule : C₂₂H₂₃FN₂O₆

Degré de pureté : Min. 95%

Masse moléculaire : 430.4 g/mol

Ref: 3D-HDC72403